Biosimilars and the future of more affordable treatment for hematologic malignancies
iwNHL 2016: Highlights from Day 1
Catherine Bollard et al.
Lessening the economic burden of treating CLL
Managing problems in treating CLL
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian